Company Financials

Apellis Pharmaceuticals, Inc. Financials

United States dollar

business Apellis Pharmaceuticals, Inc. Company Profile

Main Stock Listing

NASDAQ: APLS

Market Capitalization $3.27 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 71.83
Forward PE -22.29
Price to Sales TTM $3.22
Price to Book MRQ $8.16
Enterprise to Revenue 3.21
Enterprise to EBITDA 39.80

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 4.43%
Operating Margin 48.67%
Return on Assets TTM 5.13%
Return on Equity TTM 14.10%

Income Statement

Revenue TTM $1,016,396,992
Revenue per Share TTM $8.09
Quarterly Revenue Growth 133.00%
Gross Profit TTM $605,049,024
EBITDA $82,083,000
Net Income to Common TTM $44,986,000
Diluted EPS TTM $0.36
Quarterly Earnings Growth YoY 132.98%

Balance Sheet

Total Cash MRQ $480,232,000
Total Cash per Share MRQ $3.80
Total Debt MRQ $
Total Debt to Equity MRQ 118.50
Current Ratio MRQ 3.54
Book Value per Share MRQ $3.17

Cash Flow

Operating Cash Flow TTM $78,863,000
Levered Free Cash Flow TTM $49,292,376

APLS Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 126,500,000
Float Shares 89,570,998
Avg 10 Volume 2,215,200
Avg 30 Volume None
Shares Short 17,247,829
Short Ratio 7.80
Short % of Shares 17.94%
% Held by Insiders 13.64%
% Held by Institutions 103.76%

Stock Price Summary

Beta 0.36
Fifty Two Week Low $16.10
Fifty Two Week High $35.57
Fifty Two Week Change -32.95%
Day 50 MA $23.16
Day 200 MA $21.91

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date